Vaccine Adverse Event Reporting System Browser
Easily Browse through the VAERS adverse event reports for any year by by type of vaccine, manufacturer.
The following is all the information available on report# VAERS_ID: 752038
Vaccine(s) were received on 06/17/2016
Vaccine(s) were received in the state: AL
Patient sex : M
Reaction was life threatening?: N
Patient eventually recovered from reaction ?: U
Patient eventually died?: N

The following Data for this patients ALLERGIES is available: [ ]

Description of adverse reaction: Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 17-JUN-2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at his primary care physician, for routine health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. In approximately 2016 [reported as "shortly after" receiving ZOSTAVAX], the patient began to experience trouble in raising his right foot, and pain traveling up his right leg emanating from his right foot. The patient presented to a neurologist and was diagnosed with multifocal motor neuropathy. Thereafter (exact date not provided), the patient presented to a pathologist and was diagnosed as suffering from polyradiculoneuropathy and c


Vaccine(s) associated with report# 752038

TypeNameManufacturerVaccine LOT #Dose SeriesROUTESite
VARZOSZOSTER (ZOSTAVAX) MERCK & CO. INC.0

Symptoms(s) associated with report# 752038

Chronic inflammatory demyelinating polyradiculoneuropathy
Herpes zoster
Mobility decreased
Multifocal motor neuropathy
Pain in extremity
Polyneuropathy